Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds

Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds

Organoruthenium pyrithione (1-hydroxypyridine-2-thione) complexes have been shown in our recent studies to be a promising family of compounds for development of new anticancer drugs. The complex [(η<sup>6</sup>-<i>p</i>-cymene)Ru(pyrithionato)(pta)]PF<sub>6</sub>...

Full description

Bibliographic Details
Main Authors: Jakob Kljun, Mihaela Rebernik, Lucía M. Balsa, Jerneja Kladnik, Uroš Rapuš, Tomaž Trobec, Kristina Sepčić, Robert Frangež, Ignacio E. León, Iztok Turel
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Molecules
Subjects:
ruthenium
pyrithione
phosphines
anticancer activity
glutathione S-transferase
Online Access:https://www.mdpi.com/1420-3049/28/6/2499

Internet

https://www.mdpi.com/1420-3049/28/6/2499

Similar Items